Literature DB >> 19629679

Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.

Theodoros N Sergentanis1, Konstantinos P Economopoulos.   

Abstract

Caspase-8 (CASP8) is an initiator caspase implicated in the process of apoptosis in breast cancer cells. Attention has been drawn upon two polymorphisms: CASP8 D302H (rs1045485) and, more recently, CASP8 -652 6N del (rs3834129). The CASP8 -652 6N del polymorphism remains an open field, as studies are controversial. This meta-analysis aims to examine: (i) the association between CASP8 -652 6N del and breast cancer risk, separately in Chinese and Caucasian populations, and (ii) the association between CASP8 D302H and breast cancer risk. Eligible articles were identified by a search of MEDLINE, Cochrane, and EMBASE bibliographical databases for the period from June 1996 to July 2009. Regarding -652 6N del, five case-control studies were eligible (12,439 breast cancer cases, 13,253 controls) and four case-control studies were eligible for D302H (18,791 breast cancer cases, 20,318 controls). In case significant heterogeneity was detected, the random effects model was chosen; nevertheless, the fixed effects estimates are also secondarily reported as an alternative approach. Where appropriate, power calculations were performed. CASP8 -652 6N del was associated with reduced breast cancer risk at a borderline level (for del carriers: pooled OR = 0.884, 95% CI: 0.761-1.028); the power calculation pointed to lack of power in the individual studies. In the Caucasian populations, the same results seem valid (for del carriers: pooled OR = 0.944, 95% CI: 0.884-1.008). The random effects model in Chinese subjects has not reached statistical significance (for del carriers: pooled OR = 0.811, 95% CI: 0.492-1.338). CASP8 D302H was associated with reduced breast cancer risk (for H carriers: pooled OR = 0.874, 95% CI: 0.834-0.917). In conclusion, both CASP8 -652 6N del and D302H polymorphisms are associated with reduced cancer risk. Further studies are needed to gain the optimal power on -652 6N del, especially in Chinese subjects, as well as to gain insight into D302H in Chinese populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629679     DOI: 10.1007/s10549-009-0471-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  19 in total

1.  Breast cancer susceptibility variants alter risk in familial ovarian cancer.

Authors:  A Latif; H J McBurney; S A Roberts; F Lalloo; A Howell; D G Evans; W G Newman
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies.

Authors:  Ming Yin; Jingrong Yan; Sheng Wei; Qingyi Wei
Journal:  Carcinogenesis       Date:  2010-02-22       Impact factor: 4.944

3.  Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

4.  HTERT MNS16A polymorphism in breast cancer: a case-control study.

Authors:  Flora Zagouri; Theodoros N Sergentanis; Maria Gazouli; Alexandra Tsigginou; Constantine Dimitrakakis; Evaggelos Eleutherakis-Papaiakovou; Irene Papaspyrou; Dimosthenis Chrysikos; George Theodoropoulos; George C Zografos; Aris Antsaklis; Athanassios-Meletios Dimopoulos; Christos A Papadimitriou
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

5.  A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk.

Authors:  Yinliang Zhang; Wei Li; Yi Hong; Guoying Wu; Kan He; Dahai Liu
Journal:  J Genet       Date:  2017-06       Impact factor: 1.166

6.  Caspase-8 polymorphisms and risk of oral squamous cell carcinoma.

Authors:  Y I Tang; Yang Liu; Wei Zhao; Tao Yu; Haiyang Yu
Journal:  Exp Ther Med       Date:  2015-10-26       Impact factor: 2.447

7.  Fine-mapping CASP8 risk variants in breast cancer.

Authors:  Nicola J Camp; Marina Parry; Stacey Knight; Ryan Abo; Graeme Elliott; Sushilaben H Rigas; Sabapathy P Balasubramanian; Malcolm W R Reed; Helen McBurney; Ayse Latif; William G Newman; Lisa A Cannon-Albright; D Gareth Evans; Angela Cox
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-04       Impact factor: 4.254

8.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

9.  Combined effect of low-penetrant SNPs on breast cancer risk.

Authors:  S Harlid; M I L Ivarsson; S Butt; E Grzybowska; J E Eyfjörd; P Lenner; A Försti; K Hemminki; J Manjer; J Dillner; J Carlson
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

10.  Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.

Authors:  Nicole A Lavender; Erica N Rogers; Susan Yeyeodu; James Rudd; Ting Hu; Jie Zhang; Guy N Brock; Kevin S Kimbro; Jason H Moore; David W Hein; La Creis R Kidd
Journal:  BMC Med Genomics       Date:  2012-04-30       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.